Latest News
Private equity firm GTCR has submitted a proposal to acquire Fundtech, a leading provider of transaction banking software and services to financial institutions, for USD23.33 in cash for each Fundtech ordinary share.
GTCR intends to combine Fundtech and BankServ, a GTCR portfolio company, creating a global leader in the growing market for payments and banking technology delivered to financial institutions and corporations.
Fundtech’s Board of Directors has determined that the GTCR Proposal constitutes a “Company Superior Offer” under Fundtech’s previously announced merger agreement with S1 Corporation (S1). Fundtech has delivered the required notice to S1 of its intent to
Monroe Capital has funded a USD22.5 million unitranche facility and an equity co-investment in West World Media, LLC. Monroe Capital’s facility was used to refinance existing debt and provide growth capital.
West World Media, LLC supplies movie theatre showtimes, movie content, advertising services, marketing services, web-hosting services, and local event data on a global basis. West World Media’s customer base consists of a diverse group of leading global search engines, mobile applications, movie theaters, and newspapers.
Jeremy VanDerMeid (pictured), Managing Director at Monroe Capital, says: “We worked closely with Brett West and his entrepreneurial team to structure a creative one-stop
The Aureos South-East Asia Fund II (ASEAF II) has completed an MBO transaction of a leading Indonesian engineering company, ODG Wormald Indonesia (ODG).
ASAEF II, which is currently fundraising with a target of US$250m, is a regional private equity fund focusing on investments in South East Asia, particularly Indonesia, Thailand, Vietnam, the Philippines and Malaysia. Aureos has offices in all 5 countries, as well as Singapore, staffed by senior investment teams with extensive regional private equity experience.
ODG is the leading mechanical and engineering contractor in Indonesia to offer a full range of mechanical and electrical and fire systems services
The Alternative Investment Management Association (AIMA), the global hedge fund association, has responded to a consultation by the European Securities and Markets Authority (ESMA) on how the Alternative Investment Fund Managers Directive (AIFMD) should be implemented.
ESMA, which is responsible for advising the European Commission on the implementing measures for the AIFMD, sought feedback on a consultation paper it circulated in July.
AIMA said many of ESMA’s draft proposals were “measured”, but several major areas of concern remained, including proposals relating to depositaries, leverage, valuation, transparency and liquidity management. So-called third country (non-EU) issues are covered by a separate
Newly-launched, location-based mobile gaming start-up Red Robot Labs has raised USD8.5 million in funding led by Benchmark Capital. Benchmark’s Mitch Lasky will be joining the company’s board of directors.
Shasta Ventures and existing investors Rick Thompson, co-founder of Playdom, and Chamath Palihapitiya, former Facebook executive, also participated in the Series A funding round. The company will use the financing to accelerate studio growth, propel development of their R2 location gaming platform, build third party studio partnerships, and deliver the most sophisticated and engaging games for mobile devices.
"Benchmark is focused on helping great entrepreneurs build successful companies," says Mitch
Global alternative investment firm Investcorp has appointed Savio Tung as Chief Executive Officer, North America.
Tung returns to a full time role at Investcorp, where he was one of the founding partners and served from 1984 until 2009, from 1995 until 2000 as Head of Corporate Investment, North America and from 2001 to 2009 as Head of Technology Investment. From 2009, Tung served as an advisor to Investcorp and as Chairman of its Technology Investment Committee, combining this with a number of board positions, including a role with Bank of China, Hong Kong Limited.
He re-joins as Investcorp, last month,
Kelso Place Asset Management LLP (Kelso Place), the special situations investor, has appointed Philip Dougall as Partner. The appointment takes Kelso Place’s London-based investment team to nine.
Sion Kearsey, Managing Partner of Kelso Place, says: “Phil has a wealth of experience and knowledge of the turnaround landscape, which will be vital for us as we prepare for a period of increased deal flow. In particular, the experience he garnered from his time at Sun European Partners showcases his skills, which we are confident will be much in demand in the coming months. I am delighted that he has chosen to
Crescent Capital, a Turkey-based fund manager focused on energy and infrastructure, has successfully launched and held the first closing of Clean Energy Transition Fund, LP (CETF), a private equity fund targeting investments in renewable energy generation projects and related sectors, predominantly in Turkey and South Eastern Europe.
CETF, which will be managed by Crescent Capital Advisory Ltd, aims to take advantage of significant investment opportunities in Turkey and neighbouring regions in the field of wind, hydro, biomass, geothermal, and solar power projects.
CETF’s first closing at EUR65 million has been supported by EBRD, EIB, iVCi, FMO, and DEG, which have
Chicago-based private equity firm Winona Capital Management, along with existing investors, has made a strategic investment in Petsense, a rapidly growing US chain of specialty pet supply retail stores.
“We are extremely excited to partner with Petsense. Bob Angstead (Petsense CEO) and his team have sharpened the pet retail model,” says Winona Managing Director Laird Koldyke. “With this capital infusion, Petsense will accelerate the expansion of their proven retail and distribution model nationwide.”
Winona’s investment will allow Petsense to rapidly build 100+ new stores throughout targeted markets in the United States. Petsense currently has 50 company owned stores in 16
Forbion Capital Partners’ portfolio company AM-Pharma BV, a biopharmaceutical company focused on the preclinical and clinical development of Alkaline Phosphatase (AP) as a treatment of severe inflammatory diseases, has raised EUR29.2m in an oversubscribed Series D financing.
The series D round was led by Ysios Capital Partners, co-led by Kurma Life Science Partners and supported by a consortium including the venture arms of two global Healthcare companies, Abbott and Shire, the European venture funds, BB Biotech Ventures and Idinvest Partners as well as existing investors, Forbion Capital Partners and Inventages Venture Capital.
The current fundraising will enable AM-Pharma to
Special Reports
Featured
- Insight
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
